From: Role of HOXA1-4 in the development of genetic and malignant diseases
Diseases | Expression | Regulate genes | pathways | Functions | References |
---|---|---|---|---|---|
HOXA-AS2 | |||||
 Chronic intermittent hypoxia (CIH)-induced lung inflammation | Down | miR-17-5p | miR-17-5p/tipe2 | Inflammatory regulator | [138] |
 Diabetic nephropathy | Down | miRNA-302b-3p | miRNA-302b-3p/TIMP3 | Inflammation, apoptosis | [137] |
 Epilepsy | Up | miR-372-3p | miR-372-3p/STAT3 | Cellular damages | [141] |
 Parkinson's disease | Up | PRC2, PGC-1α |  | Neuroinflammation | [142] |
 Systemic lupus erythematosus | Up |  | ERK pathway |  | [143] |
 Vascular disorders |  |  | NF-κB signaling | Endothelium inflammation | [140] |
 VSMCs injury | Up | miRNA-877-3p |  | Proliferation, apoptosis, and migration | [139] |
HOXA-AS3 | |||||
 Atherosclerosis | Up | miR-455-5p | miR-455-5p /p27 Kip1 | Proliferation, apoptosis | [144] |
 Endothelium inflammation |  |  | NF-κB |  | [145] |
 Pulmonary arterial hypertension | Up | miR-675-3p | miR-675-3p/PDE5A | Proliferation, viability, and migration | [146] |